Rheb1 promotes tumor progression through mTORC1 in MLL-AF9-initiated murine acute myeloid leukemia

被引：0
|
作者：
Yanan Gao
Juan Gao
Minghao Li
Yawei Zheng
Yajie Wang
Hongyan Zhang
Weili Wang
Yajing Chu
Xiaomin Wang
Mingjiang Xu
Tao Cheng
Zhenyu Ju
Weiping Yuan
机构：
[1] CAMS & PUMC,State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Center for Stem Cell Medicine
[2] University of Miami,Department of Biochemistry and Molecular Biology, Miller School of Medicine
[3] Hangzhou Normal University,Institute of Aging
来源：
Journal of Hematology & Oncology | / 9卷
关键词：
Rheb1; mTORC1; MLL-AF9; Leukemia; Rapamycin; 3BDO;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] G1 cell-cycle arrest and apoptosis by histone deacetylase inhibition in MLL-AF9 acute myeloid leukemia cells is MLL-AF9 independent
    Tonelli, R
    Sartini, R
    Fronza, R
    Freccero, F
    Franzoni, M
    Dongiovanni, D
    Ballarini, M
    Ferrari, S
    D'Apolito, M
    Di Cola, G
    Capranico, G
    Khobta, A
    Campanini, R
    Paolucci, P
    Minucci, S
    Pession, A
    BLOOD, 2005, 106 (11) : 181B - 181B
  • [22] Enhancing the effectiveness of nucleoside analogs with mTORC1 blockers to treat acute myeloid leukemia patients
    Martelli, Alberto M.
    Lonetti, Annalisa
    Amadori, Sergio
    McCubrey, James A.
    Chiarini, Francesca
    CELL CYCLE, 2013, 12 (12) : 1815 - 1816
  • [23] Co-activation of AMPK and mTORC1 as a new therapeutic option for acute myeloid leukemia
    Sujobert, Pierre
    Tamburini, Jerome
    MOLECULAR & CELLULAR ONCOLOGY, 2016, 3 (04):
  • [24] Lowering mTORC1 Drives CAR T-Cells Home in Acute Myeloid Leukemia
    Maiti, Abhishek
    Daver, Naval G.
    CLINICAL CANCER RESEARCH, 2021, 27 (21) : 5739 - 5741
  • [25] Twist family BHLH transcription factor 1 is required for the maintenance of leukemia stem cell in MLL-AF9+acute myeloid leukemia
    Wang, Nan
    Yin, Jing
    You, Na
    Zhu, Wenqi
    Guo, Nini
    Liu, Xiaoyan
    Zhang, Peiwen
    Huang, Wanling
    Xie, Yueqiao
    Ren, Qian
    Ma, Xiaotong
    HAEMATOLOGICA, 2024, 109 (01) : 84 - 97
  • [26] Pre-clinical activity of combined LSD1 and mTORC1 inhibition in MLL-translocated acute myeloid leukaemia
    Gauri Deb
    Bettina Wingelhofer
    Fabio M. R. Amaral
    Alba Maiques-Diaz
    John A. Chadwick
    Gary J. Spencer
    Emma L. Williams
    Hui-Sun Leong
    Tamara Maes
    Tim C. P. Somervaille
    Leukemia, 2020, 34 : 1266 - 1277
  • [27] Pre-clinical activity of combined LSD1 and mTORC1 inhibition in MLL-translocated acute myeloid leukaemia
    Deb, Gauri
    Wingelhofer, Bettina
    Amaral, Fabio M. R.
    Maiques-Diaz, Alba
    Chadwick, John A.
    Spencer, Gary J.
    Williams, Emma L.
    Leong, Hui-Sun
    Maes, Tamara
    Somervaille, Tim C. P.
    LEUKEMIA, 2020, 34 (05) : 1266 - 1277
  • [28] Loss of BCAA Catabolism during Carcinogenesis Enhances mTORC1 Activity and Promotes Tumor Development and Progression
    Ericksen, Russell E.
    Lim, Siew Lan
    McDonnell, Eoin
    Shuen, Wai Ho
    Vadiveloo, Maya
    White, Phillip J.
    Ding, Zhaobing
    Kwok, Royston
    Lee, Philip
    Radda, George K.
    Toh, Han Chong
    Hirschey, Matthew D.
    Han, Weiping
    CELL METABOLISM, 2019, 29 (05) : 1151 - +
  • [29] Improved classification of MLL-AF9-positive acute myeloid leukemia patients based on BRE and EVI1 expression
    Noordermeer, Sylvie M.
    Monteferrario, Davide
    Sanders, Mathijs A.
    Bullinger, Lars
    Jansen, Joop H.
    van der Reijden, Bert A.
    BLOOD, 2012, 119 (18) : 4335 - 4337
  • [30] Co-activation of AMPK and mTORC1 A therapeutic application of synthetic lethality in acute myeloid leukemia
    Tamburini, Jerome
    Poulain, Laury
    Bouscary, Didier
    Sujobert, Pierre
    M S-MEDECINE SCIENCES, 2015, 31 (10): : 837 - 841
12345